BIOSIG TECHNOLOGIES, INC. BSGM Income Statement

Biosig technologies, inc. (BSGM)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Sep'13	Jun'13
Operating expenses:
Research and development
13,176	9,738	6,263	5,363	4,995	4,368	4,010	4,390	4,280	4,756	4,370	3,806	3,620	2,654	2,446	2,240	1,577	1,506	1,327	1,117	727	547	656	690	0	0	0
General and administrative
28,287	24,810	18,769	17,334	15,488	12,881	12,609	10,990	8,352	8,138	5,208	5,413	8,117	8,499	9,036	10,161	9,718	10,526	11,223	12,903	9,449	7,304	5,391	2,637	0	0	0
Depreciation and amortization
67	54	39	23	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation
-	-	-	-	-	-	-	-	11	11	11	11	10	10	10	10	10	10	11	12	14	15	16	17	0	0	0
Total operating expenses
41,531	34,603	25,073	22,722	20,500	17,262	16,631	15,393	12,644	12,906	9,590	9,231	11,748	11,164	11,493	12,412	11,306	12,044	12,563	14,033	10,191	7,868	6,064	3,345	0	0	0
Loss from operations
-41,531	-34,603	-25,073	-22,722	-20,500	-17,262	-16,631	-15,393	-12,644	-12,906	-9,590	-9,231	-11,748	-11,164	-11,493	-12,412	-11,306	-12,044	-12,563	-14,033	-10,191	-7,868	-6,064	0	0	0	-
Loss from operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Other income (expense):
Gain on change in fair value of derivatives
-	-	-	-	-	-	-	-	584	210	64	-31	-528	-422	-743	2,090	2,845	3,113	3,050	198	0	-	0	0	-	-	-
Interest income, net
166	132	93	55	16	10	2	0	0	0	0	0	0	0	0	0	-0	-1	-2	-3	-11	-11	-9	-9	0	0	0
Gain on disposal of assets
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	593	2,384	0	0	0	-
Total other income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	2,315	2,582	0	0	0	-	-	-	-	-	-
Total other income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-
Financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Loss before income taxes
-41,364	-34,470	-24,979	-22,666	-20,483	-17,251	-16,098	-14,748	-12,060	-12,695	-9,526	-9,263	-12,276	-11,587	-12,237	-10,322	-8,991	-9,461	-10,044	-14,382	-10,408	-8,473	-8,459	-6,338	0	0	0
Income taxes (benefit)
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net loss
0	-	0	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Preferred stock dividend
19	25	124	314	590	884	831	659	401	119	93	95	101	110	192	220	304	351	314	324	295	300	314	327	0	0	0
Net loss attributable to common stockholders
-41,383	-34,495	-25,104	-22,980	-21,074	-18,136	-16,930	-15,407	-12,461	-12,815	-9,619	-9,359	-12,378	-11,697	-12,429	-10,543	-9,295	-9,812	-10,359	-14,707	-10,704	-8,773	-8,773	-6,665	0	0	0
Non-controlling interest
0	-	0	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.
-39,540	-34,079	-25,664	-23,561	-21,379	-18,136	-16,293	-14,748	-12,060	-12,695	-9,526	-9,263	-12,276	-11,587	-12,237	-10,322	-8,991	-9,461	-10,044	-14,382	-10,408	-8,473	-8,459	-6,338	0	0	0
Net loss per common share, basic and diluted (in Dollars per share)
-0.46	-0.69	-0.25	-0.38	-0.33	-0.50	-0.22	-0.44	-0.09	-0.82	-0.17	-0.12	-0.14	-0.05	-0.08	-0.32	-0.15	-0.11	0.02	-0.35	-0.26	-0.28	-0.39	-0.10	-0.14	-0.33	-0.23
Weighted average number of common shares outstanding, basic and diluted (in Shares)
24,389	22,449	21,809	20,671	17,848	-1,263	15,529	13,807	29,944	-17,730	10,428	25,131	23,051	21,431	20,581	18,875	17,074	15,453	14,849	13,852	12,256	11,117	10,218	8,782	8,482	8,192	8,185